Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Embecta (Nasdaq: EMBC), a global diabetes care company specializing in insulin delivery, has announced it will host a conference call to discuss its fiscal first quarter 2025 financial results on Thursday, February 6, 2025, at 8:00 a.m. Eastern Time. The event will include an operational update and a Q&A session.
Participants can access the live webcast through the company’s investor relations website at investors.embecta.com. A replay of the webcast will be available starting at 11:00 a.m. ET on the same day and will remain accessible on the website for one year.
Embecta (Nasdaq: EMBC), un’azienda globale nel settore della cura del diabete specializzata nella somministrazione di insulina, ha annunciato che terrà una conferenza telefonica per discutere i risultati finanziari del primo trimestre fiscale 2025 il giovedì 6 febbraio 2025, alle 8:00 ora orientale. L’evento includerà un aggiornamento operativo e una sessione di domande e risposte.
I partecipanti possono accedere alla diretta tramite il sito web delle relazioni con gli investitori dell’azienda su investors.embecta.com. Una registrazione della diretta sarà disponibile a partire dalle 11:00 ET lo stesso giorno e rimarrà accessibile sul sito per un anno.
Embecta (Nasdaq: EMBC), una empresa global de atención a la diabetes especializada en la entrega de insulina, ha anunciado que celebrará una conferencia telefónica para discutir los resultados financieros del primer trimestre fiscal 2025 el jueves 6 de febrero de 2025, a las 8:00 a.m. hora del Este. El evento incluirá una actualización operativa y una sesión de preguntas y respuestas.
Los participantes pueden acceder a la transmisión en vivo a través del sitio web de relaciones con inversores de la empresa en investors.embecta.com. Una repetición de la transmisión estará disponible a partir de las 11:00 a.m. ET el mismo día y permanecerá accesible en el sitio durante un año.
Embecta (Nasdaq: EMBC)는 인슐린 전달을 전문으로 하는 글로벌 당뇨병 관리 회사로, 2025 회계 연도 첫 분기 재무 결과를 논의하기 위한 컨퍼런스 콜을 2025년 2월 6일 목요일 오전 8:00 동부 시간에 개최할 것이라고 발표했습니다. 이번 행사에는 운영 업데이트와 질문 및 답변 세션이 포함됩니다.
참석자는 회사의 투자자 관계 웹사이트인 investors.embecta.com을 통해 라이브 웹캐스트에 접근할 수 있습니다. 당일 오전 11:00 ET부터 웹캐스트의 재생이 가능하며, 웹사이트에서는 1년 동안 접근할 수 있습니다.
Embecta (Nasdaq: EMBC), une entreprise mondiale spécialisée dans les soins du diabète et la livraison d’insuline, a annoncé qu’elle tiendrait une conférence téléphonique pour discuter de ses résultats financiers du premier trimestre fiscal 2025 le jeudi 6 février 2025 à 8h00, heure de l’Est. L’événement comprendra une mise à jour opérationnelle et une session de questions-réponses.
Les participants peuvent accéder à la diffusion en direct via le site web des relations avec les investisseurs de l’entreprise à l’adresse investors.embecta.com. Un replay de la diffusion sera disponible à partir de 11h00 ET le même jour et sera accessible sur le site pendant un an.
Embecta (Nasdaq: EMBC), ein globales Unternehmen für Diabetesversorgung, das sich auf die Insulinabgabe spezialisiert hat, hat angekündigt, dass es am Donnerstag, den 6. Februar 2025, um 8:00 Uhr Eastern Time eine Telefonkonferenz abhalten wird, um die finanziellen Ergebnisse des fiskalischen ersten Quartals 2025 zu erörtern. Die Veranstaltung wird ein operatives Update und eine Frage-und-Antwort-Runde beinhalten.
Teilnehmer können über die Investor-Relations-Website des Unternehmens unter investors.embecta.com auf das Live-Webcast zugreifen. Eine Wiederholung des Webcasts wird am selben Tag ab 11:00 Uhr ET verfügbar sein und bleibt ein Jahr lang auf der Website zugänglich.
PARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal first quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, February 6, 2025.
Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on February 6, 2025, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations |
Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR |
FAQ
When will Embecta (EMBC) release its Q1 2025 earnings?
Embecta will release its fiscal first quarter 2025 earnings on Thursday, February 6, 2025, at 8:00 a.m. Eastern Time.
How can investors access Embecta’s (EMBC) Q1 2025 earnings call?
Investors can access the live webcast through Embecta’s investor relations website at investors.embecta.com or via the provided teleconference link.
How long will Embecta’s (EMBC) Q1 2025 earnings call replay be available?
The webcast replay will be available beginning at 11:00 a.m. ET on February 6, 2025, and will be archived on the company’s investor relations website for one year.
What will be discussed during Embecta’s (EMBC) Q1 2025 earnings call?
The call will discuss fiscal first quarter 2025 financial results, provide an operational update, and include a question and answer session.
